https://www.pacificbridgemedical.com/news-brief/taiwan-s-pharmaceutical-industry-market-overview/ 2025-02-03T20:59:32+00:00 https://www.pacificbridgemedical.com/news-brief/asian-harmonization-working-party-issues-final-documents-on-safety-alert-dissemination-system/ 2025-02-03T20:53:57+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-and-drug-updates/ 2025-02-03T18:55:39+00:00 https://www.pacificbridgemedical.com/news-brief/japan-expects-to-approve-and-list-for-nhi-pricing-43-novel-drugs-in-2025/ 2025-02-03T18:54:19+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-revised-change-management-program-for-samd-products/ 2025-02-03T18:54:12+00:00 https://www.pacificbridgemedical.com/news-brief/quick-korean-medical-device-regulatory-updates/ 2025-02-03T18:54:10+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-drug-volume-based-procurement-policy-shows-some-cracks/ 2025-02-03T18:54:06+00:00 https://www.pacificbridgemedical.com/news-brief/indias-new-data-protection-standards-and-its-impact-on-pharma-industry/ 2025-02-03T18:54:03+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asian-drug-regulatory-updates/ 2025-02-03T18:53:55+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-draft-administrative-rules-to-regulate-medical-representatives/ 2025-02-03T18:53:51+00:00 https://www.pacificbridgemedical.com/news-brief/korea-continues-to-issue-new-regulations-to-expedite-drug-approval/ 2025-02-03T18:53:48+00:00 https://www.pacificbridgemedical.com/news-brief/western-drug-executives-pause-some-activities-in-china-except-for-innovative-drug-research-and-development/ 2025-02-03T18:53:43+00:00 https://www.pacificbridgemedical.com/news-brief/japan-s-mhlw-looks-to-increased-budget-for-device-and-drug-oversight/ 2025-02-03T13:56:41+00:00 https://www.pacificbridgemedical.com/news-brief/asia-generic-drugs-to-become-greater-percentage-of-pharmaceutical-sales/ 2025-02-02T20:27:13+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-introduce-compassionate-use-drug-pathway/ 2025-01-30T21:17:20+00:00 https://www.pacificbridgemedical.com/news-brief/asean-to-push-for-regulatory-integration-for-medical-device/ 2025-01-30T21:17:07+00:00 https://www.pacificbridgemedical.com/news-brief/registering-medical-devices-in-china-required-documents/ 2025-01-30T21:12:51+00:00 https://www.pacificbridgemedical.com/news-brief/opportunities-in-asias-expanding-self-care-market/ 2025-01-30T21:11:58+00:00 https://www.pacificbridgemedical.com/news-brief/medical-device-conformity-assessment-for-asean-countries/ 2025-01-30T21:11:17+00:00 https://www.pacificbridgemedical.com/news-brief/japan-establishes-points-for-drug-review-process/ 2025-01-30T20:43:28+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-issues-new-classification-codes-for-ivds-that-come-into-effect-on-january-1-2025/ 2025-01-30T20:36:30+00:00 https://www.pacificbridgemedical.com/news-brief/japan-speeds-up-drug-and-device-review-process/ 2025-01-30T19:54:31+00:00 https://www.pacificbridgemedical.com/news-brief/japan-pharmaceutical-companies-look-for-overseas-deals/ 2025-01-29T22:06:27+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-adopt-compassionate-use-system-and-open-drug-market-to-foreign-companies/ 2025-01-29T22:05:55+00:00 https://www.pacificbridgemedical.com/news-brief/changing-landscape-for-multinationals-in-the-philippine-pharmaceutical-market/ 2025-01-29T21:53:19+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-to-change-procedure-for-tissue-engineered-product-approval/ 2025-01-29T21:49:19+00:00 https://www.pacificbridgemedical.com/news-brief/japan-new-gcp-updates-on-written-informed-consent/ 2025-01-29T21:21:27+00:00 https://www.pacificbridgemedical.com/news-brief/japanese-universities-team-up-to-speed-medical-testing/ 2025-01-29T20:49:08+00:00 https://www.pacificbridgemedical.com/news-brief/japans-acceptance-of-foreign-clinical-data-progress-remains-slow/ 2025-01-29T20:43:49+00:00 https://www.pacificbridgemedical.com/news-brief/building-a-virtual-drug-development-laboratory-in-japan/ 2025-01-29T20:42:52+00:00 https://www.pacificbridgemedical.com/news-brief/m-a-in-japan-foreign-companies-increase-presence-in-japanese-healthcare-market/ 2025-01-29T20:42:36+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-to-adopt-asean-common-technical-dossier-and-common-technical-requirements-soon/ 2025-01-29T20:41:32+00:00 https://www.pacificbridgemedical.com/news-brief/japans-ministry-of-health-labor-and-welfare-an-overview/ 2025-01-29T20:40:18+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-priorities-for-national-health-care-reform/ 2025-01-28T15:30:46+00:00 https://www.pacificbridgemedical.com/news-brief/eu-korea-free-trade-agreement-adds-competition-for-us-pharmaceutical-companies/ 2025-01-28T15:29:35+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-s-pharmaceutical-market-local-manufacturers-gaining-market-share/ 2025-01-28T15:27:57+00:00 https://www.pacificbridgemedical.com/news-brief/updates-on-india-s-medical-regulations/ 2025-01-28T15:27:34+00:00 https://www.pacificbridgemedical.com/news-brief/japan-s-reimbursement-regulatory-update/ 2025-01-28T15:23:46+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-officials-meet-to-curb-rising-drug-prices/ 2025-01-28T15:22:17+00:00 https://www.pacificbridgemedical.com/news-brief/china-s-pharmaceutical-regulatory-system-and-collaboration-with-the-u-s-fda/ 2025-01-28T15:20:28+00:00 https://www.pacificbridgemedical.com/news-brief/market-access-in-china-drug-listing-bidding-pricing-and-reimbursement/ 2025-01-28T15:15:51+00:00 https://www.pacificbridgemedical.com/news-brief/indian-state-further-reduces-drug-eluting-stent-cost/ 2025-01-28T15:13:55+00:00 https://www.pacificbridgemedical.com/news-brief/india-increases-inspections-of-foreign-drug-manufacturers/ 2025-01-28T15:09:05+00:00 https://www.pacificbridgemedical.com/news-brief/china-initiates-foreign-gmp-inspections/ 2025-01-28T14:53:50+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-increased-opportunities-for-foreign-drug-manufacturers/ 2025-01-28T14:44:09+00:00 https://www.pacificbridgemedical.com/news-brief/good-distributors-the-key-to-successfully-selling-medical-devices-in-japan-and-china/ 2025-01-28T13:55:57+00:00 https://www.pacificbridgemedical.com/news-brief/u-s-food-and-drug-administration-news-150226/ 2025-01-28T13:55:40+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-pharmaceutical-market-reforms/ 2025-01-28T13:53:51+00:00 https://www.pacificbridgemedical.com/news-brief/china-s-new-and-updated-gmp-regulations-for-medical-products/ 2025-01-28T13:53:34+00:00 https://www.pacificbridgemedical.com/news-brief/further-crackdowns-on-rebates-in-korea/ 2025-01-28T12:51:05+00:00 https://www.pacificbridgemedical.com/news-brief/japan-issues-minor-changes-to-fma-application/ 2025-01-28T12:47:55+00:00 https://www.pacificbridgemedical.com/news-brief/the-philippines-cracks-down-on-drug-price-reduction-violations/ 2025-01-27T22:01:10+00:00 https://www.pacificbridgemedical.com/news-brief/public-hearing-for-revised-fee-schedule-issued-by-filipino-food-and-drug-administration/ 2025-01-27T22:00:55+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-automatic-renewals-of-licenses-to-operate/ 2025-01-27T22:00:27+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-pharmaceutical-registration-an-overview/ 2025-01-27T22:00:11+00:00 https://www.pacificbridgemedical.com/news-brief/asean-plans-to-reduce-non-tariff-barriers-for-cosmetics-and-pharmaceuticals/ 2025-01-27T21:59:59+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-reorganize-bureau-of-food-and-drugs-bfad-under-republic-act-9711/ 2025-01-27T21:50:58+00:00 https://www.pacificbridgemedical.com/news-brief/revision-of-the-japanese-pharmaceutical-affairs-law/ 2025-01-27T21:50:42+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-seeks-to-pass-law-regulating-drug-prices/ 2025-01-27T21:50:24+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-updated-marketing-authorization-holder-mah-procedures/ 2025-01-27T21:49:51+00:00 https://www.pacificbridgemedical.com/news-brief/japan-pneumonia-becomes-leading-cause-of-death/ 2025-01-27T21:49:38+00:00 https://www.pacificbridgemedical.com/news-brief/vietnamese-pharmaceutical-industry-government-to-invest-1-5-billion/ 2025-01-27T21:49:25+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-to-require-hologram-security-labels-for-pharmaceuticals-beginning-2005/ 2025-01-27T21:44:27+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-sfda-tightens-control-over-labeling-of-imported-medical-devices/ 2025-01-27T21:44:04+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-mandates-strict-labeling-of-medical-devices-including-implantables-and-in-vitro-devices/ 2025-01-27T21:43:51+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-renew-pending-bill-on-medical-devices/ 2025-01-27T21:43:39+00:00 https://www.pacificbridgemedical.com/news-brief/prescription-required-to-purchase-antibiotics-in-china-an-update/ 2025-01-27T21:43:15+00:00 https://www.pacificbridgemedical.com/news-brief/clinical-trial-medicines-for-incurable-disease-patients-in-korea/ 2025-01-27T21:43:02+00:00 https://www.pacificbridgemedical.com/news-brief/rise-of-imported-medical-devices-in-india-leads-to-price-control-talks/ 2025-01-27T21:42:33+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-s-new-medical-device-authority-will-require-mandatory-product-registration/ 2025-01-27T21:42:21+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-orders-foreign-drugmakers-to-manufacture-in-country/ 2025-01-27T21:42:05+00:00 https://www.pacificbridgemedical.com/news-brief/korea-regulatory-reform-medical-device-registration-and-mobile-health-products/ 2025-01-27T21:41:50+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-fda-transfers-inspection-and-approval-authority-to-regional-fdas/ 2025-01-27T21:40:38+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-lower-risk-medical-devices-subject-to-more-favorable-regulations/ 2025-01-27T21:39:33+00:00 https://www.pacificbridgemedical.com/news-brief/india-moves-to-pass-comprehensive-medical-device-regulations/ 2025-01-27T21:37:23+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-s-medical-device-market-opportunities-for-foreign-firms/ 2025-01-27T21:37:11+00:00 https://www.pacificbridgemedical.com/news-brief/koreas-pharmaceutical-market-new-developments-helpful-for-foreign-firms/ 2025-01-27T21:36:46+00:00 https://www.pacificbridgemedical.com/news-brief/proposed-stricter-regulations-for-clinical-trials-drug-imports-in-india/ 2025-01-27T21:36:29+00:00 https://www.pacificbridgemedical.com/news-brief/china-ministry-of-health-considering-ban-on-drug-advertising/ 2025-01-27T21:31:31+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-enforce-stricter-regulations-on-clinical-trials/ 2025-01-27T21:30:23+00:00 https://www.pacificbridgemedical.com/news-brief/chinese-government-responds-to-price-fluctuations-of-medical-products-due-to-sars-outbreak/ 2025-01-27T21:29:52+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-to-implement-asian-medical-device-nomenclature-system/ 2025-01-27T21:29:34+00:00 https://www.pacificbridgemedical.com/news-brief/clarifications-on-bioequivalence-be-study-requirements-in-india/ 2025-01-27T21:29:23+00:00 https://www.pacificbridgemedical.com/news-brief/product-standards-and-labeling-requirements-for-pharmaceuticals-in-india-an-overview/ 2025-01-27T21:28:51+00:00 https://www.pacificbridgemedical.com/news-brief/korea-us-free-trade-agreement-on-pharmaceuticals-and-medical-devices/ 2025-01-27T21:28:39+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-creates-center-for-drug-administration/ 2025-01-27T21:22:52+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-implements-international-standards-and-e-submission-for-pharmaceutical-approval-documents/ 2025-01-27T21:22:43+00:00 https://www.pacificbridgemedical.com/news-brief/finding-and-qualifying-distributors-in-china-the-basics/ 2025-01-27T21:21:58+00:00 https://www.pacificbridgemedical.com/news-brief/cosmetic-product-registration-in-malaysia-an-overview/ 2025-01-27T21:21:43+00:00 https://www.pacificbridgemedical.com/news-brief/an-update-on-reimbursement-for-medical-devices-in-korea/ 2025-01-27T21:20:37+00:00 https://www.pacificbridgemedical.com/news-brief/taiwans-aging-population-provides-growth-opportunity-for-foreign-medical-device-companies/ 2025-01-27T21:20:23+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-releases-new-guidance-on-minor-variation-applications-for-drugs/ 2025-01-27T21:20:09+00:00 https://www.pacificbridgemedical.com/news-brief/double-standard-for-counterfeit-drugs-in-india/ 2025-01-27T21:13:50+00:00 https://www.pacificbridgemedical.com/news-brief/korean-medical-market-device-pharmaceutical-markets-grow/ 2025-01-27T21:09:26+00:00 https://www.pacificbridgemedical.com/news-brief/malaysias-mandatory-medical-device-registration-postponed-for-one-year/ 2025-01-27T21:09:13+00:00 https://www.pacificbridgemedical.com/news-brief/huge-population-low-costs-bring-clinical-trials-to-india/ 2025-01-27T21:08:59+00:00 https://www.pacificbridgemedical.com/news-brief/vietnams-new-pharmaceutical-law-takes-effect-in-october-2005/ 2025-01-27T21:07:43+00:00 https://www.pacificbridgemedical.com/news-brief/indian-ministry-of-health-issues-notification-on-medical-device-regulation/ 2025-01-27T21:07:29+00:00 https://www.pacificbridgemedical.com/news-brief/pharmaceutical-companies-investing-in-r-d-to-facilitate-entry-into-china-s-medical-market/ 2025-01-27T21:07:15+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-require-recording-of-informed-consent-for-clinical-trials/ 2025-01-27T21:07:00+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-good-distribution-practice-gdp-certification-guidelines/ 2025-01-27T21:06:47+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-state-food-and-drug-administration-sfda-to-regulate-api/ 2025-01-27T20:47:10+00:00 https://www.pacificbridgemedical.com/news-brief/clinical-trials-in-vietnam-required-for-first-time-device-imports/ 2025-01-27T20:46:46+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-to-create-food-and-drug-administration-for-food-and-drug-safety/ 2025-01-27T20:46:14+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-launches-online-pharmaceutical-product-registration-system/ 2025-01-27T20:45:53+00:00 https://www.pacificbridgemedical.com/news-brief/pharmaceutical-industry-reform-in-china-new-drug-administrative-law/ 2025-01-27T20:45:29+00:00 https://www.pacificbridgemedical.com/news-brief/india-new-guidelines-for-import-and-manufacture-of-medical-devices-in-effect/ 2025-01-27T20:45:14+00:00 https://www.pacificbridgemedical.com/news-brief/china-us-fda-seeks-larger-budget-for-inspections/ 2025-01-27T20:45:00+00:00 https://www.pacificbridgemedical.com/news-brief/health-agencies-in-singapore-and-china-form-strategic-alliance-for-cooperation/ 2025-01-27T20:22:57+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-updated-good-distribution-practice-guidelines-for-pharmaceuticals/ 2025-01-27T20:22:45+00:00 https://www.pacificbridgemedical.com/news-brief/india-proposes-creation-of-new-agency-to-monitor-clinical-trials/ 2025-01-27T20:22:26+00:00 https://www.pacificbridgemedical.com/news-brief/pharmaceutical-sales-in-china-foreign-firms-market-share-soars/ 2025-01-27T20:22:07+00:00 https://www.pacificbridgemedical.com/news-brief/china-drug-makers-may-have-to-compromise-on-price-in-order-to-access-chinas-market/ 2025-01-27T20:21:53+00:00 https://www.pacificbridgemedical.com/news-brief/singapores-biotech-industry-government-plays-a-major-role/ 2025-01-27T20:21:37+00:00 https://www.pacificbridgemedical.com/news-brief/india-new-pharmaceuticals-policy-proposes-price-controls/ 2025-01-27T19:39:20+00:00 https://www.pacificbridgemedical.com/news-brief/growth-opportunities-for-japan-s-generic-drug-market/ 2025-01-27T19:38:48+00:00 https://www.pacificbridgemedical.com/news-brief/japans-government-amends-ban-on-mixed-medical-services/ 2025-01-27T19:38:19+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-new-listing-system-for-medical-devices/ 2025-01-24T20:19:22+00:00 https://www.pacificbridgemedical.com/news-brief/indian-government-announces-a-new-ethical-program-for-marketing-of-drugs/ 2025-01-24T20:18:53+00:00 https://www.pacificbridgemedical.com/news-brief/despite-a-rampant-increase-in-covid-19-cases-in-korea-today-the-mfds-will-resume-on-site-inspections-in-april/ 2025-01-24T20:18:40+00:00 https://www.pacificbridgemedical.com/news-brief/japan-plans-to-change-rules-on-clinical-trials/ 2025-01-24T20:18:19+00:00 https://www.pacificbridgemedical.com/news-brief/new-industry-standards-for-medical-devices-in-china/ 2025-01-24T20:18:05+00:00 https://www.pacificbridgemedical.com/news-brief/imports-of-medical-device-on-the-rise-in-philippines/ 2025-01-24T20:17:05+00:00 https://www.pacificbridgemedical.com/news-brief/applying-for-a-marketing-authorization-holder-license-in-japan/ 2025-01-24T20:16:41+00:00 https://www.pacificbridgemedical.com/news-brief/new-low-cost-supplemental-insurance-plans-in-china-offer-access-to-innovative-drugs/ 2025-01-24T20:15:58+00:00 https://www.pacificbridgemedical.com/news-brief/multiple-advantages-propel-chinas-ai-health-technology-ahead-of-the-u-s/ 2025-01-24T20:15:44+00:00 https://www.pacificbridgemedical.com/news-brief/japan-and-china-working-to-promote-global-clinical-trials/ 2025-01-24T20:15:10+00:00 https://www.pacificbridgemedical.com/news-brief/advertising-and-promotion-in-japan-shonin-required/ 2025-01-24T20:14:42+00:00 https://www.pacificbridgemedical.com/news-brief/korea-foreign-drug-companies-ask-for-postponement-of-increased-drug-fees-under-new-drug-policy/ 2025-01-24T20:13:50+00:00 https://www.pacificbridgemedical.com/news-brief/china-update-to-list-of-drugs-reimbursed-by-health-insurance-system-slashes-prices-excludes-key-foreign-made-anti-cancer-drugs/ 2025-01-24T20:13:33+00:00 https://www.pacificbridgemedical.com/news-brief/japan-s-in-country-caretaker-icc-system-an-overview/ 2025-01-24T20:13:20+00:00 https://www.pacificbridgemedical.com/news-brief/china-further-expedites-innovative-drug-approvals-in-greater-bay-area-and-yangtze-river-delta/ 2025-01-24T20:13:00+00:00 https://www.pacificbridgemedical.com/news-brief/singapores-hsa-announced-guidance-on-software-as-a-medical-device-and-clinical-decision-support-software/ 2025-01-24T20:12:28+00:00 https://www.pacificbridgemedical.com/news-brief/updates-on-taiwan-s-pharmaceutical-and-medical-devices-market/ 2025-01-24T20:11:52+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-implements-enhanced-quality-standards-for-medical-device-industry/ 2025-01-24T20:07:53+00:00 https://www.pacificbridgemedical.com/news-brief/proposed-lifting-of-goods-and-services-tax-for-healthcare-in-singapore/ 2025-01-24T20:06:25+00:00 https://www.pacificbridgemedical.com/news-brief/separate-medical-device-regulation-in-the-works-for-india/ 2025-01-24T20:05:57+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-announces-new-guidelines-for-active-pharmaceutical-ingredients-apis/ 2025-01-24T20:05:44+00:00 https://www.pacificbridgemedical.com/news-brief/india-s-government-plans-national-drug-authority-by-mid-2007/ 2025-01-24T20:05:28+00:00 https://www.pacificbridgemedical.com/news-brief/india-again-extends-class-c-and-d-medical-device-registrations-and-increases-post-market-surveillance/ 2025-01-24T20:04:55+00:00 https://www.pacificbridgemedical.com/news-brief/increased-transparency-and-efficiency-in-chinas-medical-device-regulatory-system/ 2025-01-24T20:04:37+00:00 https://www.pacificbridgemedical.com/news-brief/maximum-retail-price-mrp-compulsory-medical-device-packaging-india/ 2025-01-24T20:03:42+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-introduces-updates-to-medical-device-accessories-rules-e-registration-system/ 2025-01-24T20:03:07+00:00 https://www.pacificbridgemedical.com/news-brief/fast-tracked-registration-process-for-indian-generic-drugs-in-singapore/ 2025-01-24T20:01:49+00:00 https://www.pacificbridgemedical.com/news-brief/china-cracks-down-on-illegal-medical-device-advertisements/ 2025-01-24T20:01:03+00:00 https://www.pacificbridgemedical.com/news-brief/myanmar-lifts-trade-restrictions-medical-equipment/ 2025-01-24T19:59:57+00:00 https://www.pacificbridgemedical.com/news-brief/reduced-qms-requirements-for-class-a-device-registration-in-singapore/ 2025-01-24T19:59:45+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-manufacturers-working-to-develop-medical-device-sourcing/ 2025-01-24T19:59:01+00:00 https://www.pacificbridgemedical.com/news-brief/india-receives-good-laboratory-practices-certificate/ 2025-01-24T19:58:39+00:00 https://www.pacificbridgemedical.com/news-brief/new-nmpa-draft-guideline-regarding-registration-of-chemical-and-biological-drugs/ 2025-01-23T21:52:45+00:00 https://www.pacificbridgemedical.com/news-brief/korea-mfds-looks-to-improve-regulatory-hurdles-for-new-digital-products/ 2025-01-23T21:52:16+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-updates-its-medical-device-regulation-for-change-notifications/ 2025-01-23T21:50:22+00:00 https://www.pacificbridgemedical.com/news-brief/japan-update-on-marketing-authorization-holder-requirements-under-the-new-pal/ 2025-01-23T21:50:08+00:00 https://www.pacificbridgemedical.com/news-brief/philippine-government-investment-agency-to-provide-funding-for-low-cost-drug-program/ 2025-01-23T21:48:49+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-allow-certain-drugs-into-the-country-without-local-clinical-trials/ 2025-01-23T21:48:31+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-takes-steps-towards-legislated-medical-device-regulations/ 2025-01-23T21:48:02+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-announced-updates-on-the-special-access-route-for-medical-devices/ 2025-01-23T21:47:42+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-center-for-drug-evaluation-cde-recommends-changes-for-conditional-drug-approval/ 2025-01-23T21:47:28+00:00 https://www.pacificbridgemedical.com/news-brief/china-promulgates-updated-draft-penalties-for-devices-drugs-and-cosmetics/ 2025-01-23T21:47:13+00:00 https://www.pacificbridgemedical.com/news-brief/possible-setback-for-approval-period-reductions-in-japan/ 2025-01-23T21:46:26+00:00 https://www.pacificbridgemedical.com/news-brief/new-regulations-on-medical-device-advertising-in-china/ 2025-01-23T21:45:12+00:00 https://www.pacificbridgemedical.com/news-brief/india-s-regulated-medical-devices-to-further-face-price-regulation/ 2025-01-23T21:44:24+00:00 https://www.pacificbridgemedical.com/news-brief/unregulated-stents-in-india-poses-threat-to-consumers/ 2025-01-23T21:44:09+00:00 https://www.pacificbridgemedical.com/news-brief/china-enforces-new-quality-control-standards-for-drugs/ 2025-01-23T21:38:40+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-exempt-some-class-ii-medical-devices-from-clinical-trials/ 2025-01-23T21:38:28+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-new-interim-generative-ai-regulation-will-likely-affect-medtech-companies/ 2025-01-23T21:38:13+00:00 https://www.pacificbridgemedical.com/news-brief/increased-china-rd-spending-will-create-more-competition-for-the-western-medical-world/ 2025-01-23T21:37:53+00:00 https://www.pacificbridgemedical.com/news-brief/india-proposes-national-list-of-pharmaceutical-manufacturers/ 2025-01-23T21:37:34+00:00 https://www.pacificbridgemedical.com/news-brief/diabetes-cases-surge-in-japan-exceeding-ten-million-with-more-at-risk/ 2025-01-23T21:26:29+00:00 https://www.pacificbridgemedical.com/news-brief/korea-and-indonesia-sign-mou-on-safety-and-quality-standards/ 2025-01-23T21:25:54+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-proposes-elimination-of-country-of-origin-approval-requirement-for-medical-devices/ 2025-01-23T21:25:40+00:00 https://www.pacificbridgemedical.com/news-brief/pricing-reforms-approved-by-japan-reward-innovation-but-also-present-industry-challenges/ 2025-01-23T21:25:21+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-introduced-new-regulations-on-drugs-imported-for-clinical-trials/ 2025-01-23T21:24:54+00:00 https://www.pacificbridgemedical.com/news-brief/indian-drug-companies-growing-their-business-with-the-west-as-china-tensions-mount/ 2025-01-23T21:19:55+00:00 https://www.pacificbridgemedical.com/news-brief/poor-hospital-conditions-an-increasing-problem-in-india/ 2025-01-23T21:19:40+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-implements-new-phase-in-device-registration-system/ 2025-01-23T21:19:25+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-government-to-implement-universal-healthcare-and-expand-healthcare-industry/ 2025-01-22T21:53:19+00:00 https://www.pacificbridgemedical.com/news-brief/india-creates-new-department-to-oversee-pharmaceuticals/ 2025-01-22T21:53:06+00:00 https://www.pacificbridgemedical.com/news-brief/more-stringent-regulations-on-chinese-proprietary-medicines-in-singapore/ 2025-01-22T21:52:52+00:00 https://www.pacificbridgemedical.com/news-brief/proposal-for-listing-of-local-medical-device-manufacturers-in-hong-kong/ 2025-01-22T21:51:10+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-medical-device-authority-leads-harmonized-post-market-surveillance-for-medical-device-safety/ 2025-01-22T21:50:54+00:00 https://www.pacificbridgemedical.com/news-brief/india-s-drug-controller-general-to-take-over-copp-and-gmp-drug-certification/ 2025-01-22T21:50:39+00:00 https://www.pacificbridgemedical.com/news-brief/china-sfda-permits-unannounced-inspections-of-medical-device-manufacturers/ 2025-01-22T21:50:24+00:00 https://www.pacificbridgemedical.com/news-brief/singapores-hsa-makes-public-a-new-draft-guidance-for-device-clinical-evaluation/ 2025-01-22T21:50:06+00:00 https://www.pacificbridgemedical.com/news-brief/approval-for-the-central-drugs-authority-of-india/ 2025-01-22T21:49:27+00:00 https://www.pacificbridgemedical.com/news-brief/korea-introduces-new-medical-device-requirements/ 2025-01-22T21:37:54+00:00 https://www.pacificbridgemedical.com/news-brief/japan-phase-1-drug-clinical-trials-no-longer-needed-for-global-clinical-trials/ 2025-01-22T21:37:35+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-looks-to-expedite-approval-of-devices-that-already-have-asean-approvals/ 2025-01-22T21:34:10+00:00 https://www.pacificbridgemedical.com/news-brief/communication-meeting-with-the-chinese-cde-for-china-clinical-studies-becomes-a-requirement/ 2025-01-22T21:33:56+00:00 https://www.pacificbridgemedical.com/news-brief/mergers-of-japanese-pharmaceutical-companies-with-foreign-multinationals/ 2025-01-22T21:33:26+00:00 https://www.pacificbridgemedical.com/news-brief/cancer-is-rising-in-india-indian-government-decides-to-slash-customs-duty/ 2025-01-22T21:29:18+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-upgrade-community-medical-care-turning-health-centers-into-hospitals/ 2025-01-22T21:29:06+00:00 https://www.pacificbridgemedical.com/news-brief/rare-disease-regulatory-update-in-india-key-funding-and-policy-developments/ 2025-01-22T21:24:27+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-says-it-will-try-harder-to-help-foreign-drug-and-device-companies/ 2025-01-22T21:23:53+00:00 https://www.pacificbridgemedical.com/news-brief/manufacturing-certification-requirement-in-thailand/ 2025-01-22T21:23:34+00:00 https://www.pacificbridgemedical.com/news-brief/india-promulgates-a-national-single-window-system-nsws-to-ease-healthcare-information/ 2025-01-22T21:23:16+00:00 https://www.pacificbridgemedical.com/news-brief/korea-implements-expedited-market-entry-pathway-for-very-innovative-devices/ 2025-01-22T21:22:55+00:00 https://www.pacificbridgemedical.com/news-brief/india-approves-compulsory-license-allowing-generic-copy-of-patented-drug/ 2025-01-22T21:22:41+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-medical-device-division-introduces-medical-device-information-system/ 2025-01-22T21:21:42+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-new-drug-store-chain-to-sell-local-and-imported-drugs-at-reduced-prices/ 2025-01-22T21:21:29+00:00